Pharm 1000 Unit 1-5 Study guide (quizzes) With
Complete Solutions
What |is |the |most |rapid |route |to |the |slowest |route |for |drugs?
Intravenously, |intramuscularly, |subcutaneous, |orally
Examples |of |herbal |supplements
Ginseng, |garlic, |wort
Pharmacokinetics
the |absorption, |distribution, |metabolism, |and |excretion |of |drugs
Pharmacodynamics
Biochemical |changes |that |occur |in |the |body |as |a |result |of |taking |a |drug
Pharmaceutics
The |science |or |preparing |a |dispensing |drugs, |including |dosage |for |design |(e.g. |Tablets, |
capsules, |injections, |patches. |etc.)
Selective |drug |reaction
,A |drug |interacts |with |a |specific |receptor |sites |to |produce |the |desired |effects
Drug |tolerance
The |body's |decreased |response |to |a |drug |it |receives |over |a |period |of |time
drug |action
molecular |changes |produced |by |a |drug |when |it |binds |to |a |target |site |or |receptor
drug |dosage
Effect |of |drug |increases |with |increased |amount |of |drug |up |to |the |point |of |receptor |saturation.
drug |toxicity
When |a |client |receives |drugs |in |excessive |dosages |resulting |in |negative |physiologic |effects
Contraindications
factors |that |prevent |the |use |of |a |drug |or |treatment
If |a |drug |binds |with |an |enzyme |and |therefore |prevents |the |enzyme |from |binding |to |its |normal
|target |cell, |it |will |produce |an |effect |known |as:
Enzyme |interaction
,Pedro |is |researching |botanical |and |zoological |sources |of |drugs |to |treat |multiple |sclerosis. |He |is
|part |of |the |university |research |team |that |is |currently |experimenting |with |varying |biochemical |
composition, |and |therapeutic |effects |of |several |new |drugs.
Pharmacognosy
Liz |exam |is |case |studies |of |patients |with |similar |conditions |and |drug |therapies |to |determine |
similarities |based |on |clinical |observations
Prophylactic |therapy
Hamische |studies |various |poisons |and |is |particularly |concerned |with |the |detection |and |
treatment |of |effects |of |drugs |and |chemicals |in |adolescence.
Toxicology
What |is |the |primary |purpose |of |health |Canada |therapeutic |products |directorate?
To |ensure |the |safety, |efficacy, |and |quality |of |drug |sold |on |the |market.
Professional |association |requires |the |nurses |and |act |the |ethical |principle |of |nonmaleficence |
with |patience. |What |statement |best |exemplifies |this |principle?
Do |no |harm?
, Which |of |the |following |phases |of |the |four |clinical |phase |of |investigational |drug |focusses |on |
determining |the |drugs |ability |for |therapeutic |effect, |the |identification |of |adverse |effects, |and |
the |refinement |of |therapeutic |dose |ranges?
Phase |2: |drug |affective |study
What |is |a |placebo?
Inert |substance |that |is |not |a |drug
When |a |nurse |record |a |patient's |health |history, |what |cultural |information |about |medication |
administration |is |important |for |the |nurse |to |consider?
The |patient |will |eat |only |at |nighttime |for |the |next |four |weeks.
The |patient |does |not |eat |pork |product |(for |religious |reason)
A |study |that |involves |a |large |number |of |patients |at |research |centers, |and |is |designed |to |
monitor |for |frequent |adverse |effects |and |identify |any |associated |risk. |Double |blind, |placebo |
controlled |studies |eliminate |patient |and |research |bias.
Drug |study |phase |3
Sam |CK |balance |between |the |body |and |mind |using |cold |remedies |or |food |for |"hot" |illnesses, |
and |vice |versa.
Hispanic, |cultural |group
Complete Solutions
What |is |the |most |rapid |route |to |the |slowest |route |for |drugs?
Intravenously, |intramuscularly, |subcutaneous, |orally
Examples |of |herbal |supplements
Ginseng, |garlic, |wort
Pharmacokinetics
the |absorption, |distribution, |metabolism, |and |excretion |of |drugs
Pharmacodynamics
Biochemical |changes |that |occur |in |the |body |as |a |result |of |taking |a |drug
Pharmaceutics
The |science |or |preparing |a |dispensing |drugs, |including |dosage |for |design |(e.g. |Tablets, |
capsules, |injections, |patches. |etc.)
Selective |drug |reaction
,A |drug |interacts |with |a |specific |receptor |sites |to |produce |the |desired |effects
Drug |tolerance
The |body's |decreased |response |to |a |drug |it |receives |over |a |period |of |time
drug |action
molecular |changes |produced |by |a |drug |when |it |binds |to |a |target |site |or |receptor
drug |dosage
Effect |of |drug |increases |with |increased |amount |of |drug |up |to |the |point |of |receptor |saturation.
drug |toxicity
When |a |client |receives |drugs |in |excessive |dosages |resulting |in |negative |physiologic |effects
Contraindications
factors |that |prevent |the |use |of |a |drug |or |treatment
If |a |drug |binds |with |an |enzyme |and |therefore |prevents |the |enzyme |from |binding |to |its |normal
|target |cell, |it |will |produce |an |effect |known |as:
Enzyme |interaction
,Pedro |is |researching |botanical |and |zoological |sources |of |drugs |to |treat |multiple |sclerosis. |He |is
|part |of |the |university |research |team |that |is |currently |experimenting |with |varying |biochemical |
composition, |and |therapeutic |effects |of |several |new |drugs.
Pharmacognosy
Liz |exam |is |case |studies |of |patients |with |similar |conditions |and |drug |therapies |to |determine |
similarities |based |on |clinical |observations
Prophylactic |therapy
Hamische |studies |various |poisons |and |is |particularly |concerned |with |the |detection |and |
treatment |of |effects |of |drugs |and |chemicals |in |adolescence.
Toxicology
What |is |the |primary |purpose |of |health |Canada |therapeutic |products |directorate?
To |ensure |the |safety, |efficacy, |and |quality |of |drug |sold |on |the |market.
Professional |association |requires |the |nurses |and |act |the |ethical |principle |of |nonmaleficence |
with |patience. |What |statement |best |exemplifies |this |principle?
Do |no |harm?
, Which |of |the |following |phases |of |the |four |clinical |phase |of |investigational |drug |focusses |on |
determining |the |drugs |ability |for |therapeutic |effect, |the |identification |of |adverse |effects, |and |
the |refinement |of |therapeutic |dose |ranges?
Phase |2: |drug |affective |study
What |is |a |placebo?
Inert |substance |that |is |not |a |drug
When |a |nurse |record |a |patient's |health |history, |what |cultural |information |about |medication |
administration |is |important |for |the |nurse |to |consider?
The |patient |will |eat |only |at |nighttime |for |the |next |four |weeks.
The |patient |does |not |eat |pork |product |(for |religious |reason)
A |study |that |involves |a |large |number |of |patients |at |research |centers, |and |is |designed |to |
monitor |for |frequent |adverse |effects |and |identify |any |associated |risk. |Double |blind, |placebo |
controlled |studies |eliminate |patient |and |research |bias.
Drug |study |phase |3
Sam |CK |balance |between |the |body |and |mind |using |cold |remedies |or |food |for |"hot" |illnesses, |
and |vice |versa.
Hispanic, |cultural |group
